"Controversy Surrounds Trump-Endorsed COVID Treatment's Fatal Risks"

A new study suggests that the anti-malaria drug hydroxychloroquine, which was promoted by then-President Donald Trump as a COVID-19 treatment, may be linked to nearly 17,000 deaths during the pandemic's first wave. Despite initial small studies hinting at potential benefits, larger research found no positive impact on COVID-19 and an increased risk of death, leading to the FDA revoking its emergency use authorization. The majority of the deaths occurred in the United States, with the drug's cardiac side effects contributing to its toxicity. Researchers caution that the actual number of deaths could vary, and the global death toll could be higher if more data were available.